English   español  
Please use this identifier to cite or link to this item: http://hdl.handle.net/10261/150126
logo share SHARE logo core CORE   Add this article to your Mendeley library MendeleyBASE

Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL
Exportar a otros formatos:


Alkylglycerols reduce serum complement and plasma vascular endothelial growth factor in obese individuals

AuthorsFitó, Montserrat; Torres, Carlos F. ; Vázquez de Frutos, Luis ; Reglero, Guillermo ; Covas, María Isabel
KeywordsVascular endothelial growth factor
Complement 3
Complement 4
Issue Date2016
CitationInflammopharmacology 24(2): 127-131 (2016)
AbstractAlkylglycerols (AKGs), isolated or present in shark liver oil have anti-inflammatory properties. Complement 3 (C3) and 4 (C4) participate in lipid metabolism and in obesity, contributing to the metabolic syndrome and to the low-grade inflammation associated with obesity. In a randomized, controlled, crossover study, 26 non-diabetes obese individuals were assigned two preparations with low (LAC, 10 mg AKGs) and high (HAC, 20 mg AKGs) AKG content. Intervention periods were of 3 weeks preceded by 2-week washout periods in which shark liver oil was avoided. Cholesterol, C3, C4, and vascular endothelial growth factor (VEGF) decreased in a linear trend (P < 0.01) from baseline (control) to LAC and HAC. Values after HAC were significantly lower (P < 0.05) versus both baseline and after LAC. No adverse effects were observed or reported. Data from this pilot study open a promising field for the study of the beneficial effects of AKGs on cardiovascular risk factors in obese individuals.
Identifiersdoi: 10.1007/s10787-016-0265-4
e-issn: 1568-5608
issn: 0925-4692
Appears in Collections:(CIAL) Artículos
Files in This Item:
File Description SizeFormat 
accesoRestringido.pdf15,38 kBAdobe PDFThumbnail
Show full item record
Review this work

Related articles:

WARNING: Items in Digital.CSIC are protected by copyright, with all rights reserved, unless otherwise indicated.